Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.35 |
| ▸ | CDC25B | P30305 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL317789 | 1.00 | LMNA (0.68) | LMNABLMPTPN1ALOX15MEN1 | |
| SCHEMBL10535028 | 1.00 | LMNA (0.68) | LMNABLMPTPN1ALOX15MEN1 | |
| SCHEMBL10045742 | 1.00 | LMNA (0.68) | LMNABLMPTPN1ALOX15MEN1 | |
| SCHEMBL3575766 | 0.92 | LMNA (0.74) | LMNABLMPTPN1ALOX15MEN1 | |
| SCHEMBL3568842 | 0.92 | LMNA (0.74) | LMNABLMPTPN1ALOX15MEN1 | |
| SCHEMBL28228861 | 0.92 | LMNA (0.74) | LMNABLMPTPN1ALOX15MEN1 | |
| SCHEMBL12960699 | 0.90 | LMNA (0.70) | LMNABLMPTPN1ALOX15MEN1 | |
| SCHEMBL9060842 | 0.90 | LMNA (0.70) | LMNABLMPTPN1ALOX15MEN1 | |
| SCHEMBL16167217 | 0.90 | LMNA (0.70) | LMNABLMPTPN1ALOX15MEN1 | |
| SCHEMBL4821885 | 0.90 | LMNA (0.70) | LMNABLMPTPN1ALOX15MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8603449-B2 | Rinse-off conditioning composition comprising a near-terminal branched alcohol | THE PROCTER & GAMBLE COMPANY (US) | 2013-12-10 | — | — | US | claimed |
| EP-2593073-A2 | RINSE-OFF CONDITIONING COMPOSITION COMPRISING A NEAR-TERMINAL BRANCHED ALCOHOL | The Procter and Gamble Company (US) | 2013-05-22 | — | — | EP | claimed |
| US-20120014901-A1 | Rinse-Off Conditioning Composition Comprising a Near-Terminal Branched Alcohol | THE PROCTER & GAMBLE COMPANY | 2012-01-19 | — | — | US | claimed |
| WO-2012009522-A2 | RINSE-OFF CONDITIONING COMPOSITION COMPRISING A NEAR-TERMINAL BRANCHED ALCOHOL | THE PROCTER & GAMBLE COMPANY (US) | 2012-01-19 | — | — | WO | claimed |
| CN-108026062-B | Process for the hydroformylation of 2-substituted butadienes and process for the production of secondary products thereof, in particular ambrox | 巴斯夫欧洲公司 | 2022-04-12 | — | — | CN | disclosed |
| EP-3319951-B1 | METHOD FOR THE HYDROFORMYLATION OF 2-SUBSTITUTED BUTADIENES AND FOR THE PREPARATION OF PRODUCTS DERIVED FROM SAME, PARTICULARLY FROM AMBROX | BASF SE (DE) | 2021-09-08 | — | — | EP | disclosed |
| US-10315975-B2 | Method for the hydroformylation of 2-substituted butadienes and the production of secondary products thereof, especially ambrox | BASF SE (DE) | 2019-06-11 | — | — | US | disclosed |
| US-20180273458-A1 | METHOD FOR THE HYDROFORMYLATION OF 2-SUBSTITUTED BUTADIENES AND THE PRODUCTION OF SECONDARY PRODUCTS THEREOF, ESPECIALLY AMBROX | RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG (DE) | 2018-09-27 | — | — | US | disclosed |
| EP-3319951-A1 | METHOD FOR THE HYDROFORMYLATION OF 2-SUBSTITUTED BUTADIENES AND THE PRODUCTION OF SECONDARY PRODUCTS THEREOF, ESPECIALLY AMBROX | BASF SE (DE) | 2018-05-16 | — | — | EP | disclosed |
| EP-2969020-B1 | SPECIFIC UNSATURATED AND BRANCHED FUNCTIONAL MATERIALS FOR USE IN CONSUMER PRODUCTS | PROCTER & GAMBLE (US) | 2017-11-29 | — | — | EP | disclosed |
| EP-2969020-B1 | SPECIFIC UNSATURATED AND BRANCHED FUNCTIONAL MATERIALS FOR USE IN CONSUMER PRODUCTS | PROCTER & GAMBLE (US) | 2017-11-29 | — | — | EP | disclosed |
| EP-2328856-B1 | SPECIFIC POLYBRANCHED ALDEHYDES, ALCOHOLS SURFACTANTS AND CONSUMER PRODUCTS BASED THEREON | PROCTER & GAMBLE (US) | 2017-03-08 | — | — | EP | disclosed |
| US-7157442-B2 | Antibacterial compound | SANKYO COMPANY, LIMITED (JP) | 2007-01-02 | — | — | US | disclosed |
| EP-1209166-B1 | NOVEL A-500359 DERIVATIVES | SANKYO CO (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-20030171330-A1 | Antibacterial compound | SANKYO COMPANY, LIMITED (JP) | 2003-09-11 | — | — | US | disclosed |
| US-6511965-B2 | For therapy and prophylaxis of inflammatory disorders, autoimmune diseases or septicemia | SANKYO COMPANY, LIMITED (JP) | 2003-01-28 | — | — | US | disclosed |
| US-20020161221-A1 | Ether type lipid a 1-carboxylic acid analogs | SANKYO COMPANY, LIMITED (JP) | 2002-10-31 | — | — | US | disclosed |
| EP-1209166-A1 | NOVEL A-500359 DERIVATIVES | Sankyo Company, Limited (JP) | 2002-05-29 | — | — | EP | disclosed |
| EP-1152007-A1 | ETHER TYPE LIPID A1-CARBOXYLIC ACID ANALOGUES | Sankyo Company, Limited (JP) | 2001-11-07 | — | — | EP | disclosed |
| US-4598160-A | Intermediate phenolic compounds for the catalytic synthesis of chromans | HOFFMANN-LA ROCHE INC. (US) | 1986-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10315975-B2 | Method for the hydroformylation of 2-substituted butadienes and the production of secondary products thereof, especially ambrox | ALOX12, ALOX15, ALOX5 | LMNA 2087/4885BLM 657/4885PTPN1 4835/4885 |
| US-20180273458-A1 | METHOD FOR THE HYDROFORMYLATION OF 2-SUBSTITUTED BUTADIENES AND THE PRODUCTION OF SECONDARY PRODUCTS THEREOF, ESPECIALLY AMBROX | ALOX12, ALOX15, ALOX5 | LMNA 2087/4885BLM 657/4885PTPN1 4835/4885 |
| US-20030171330-A1 | Antibacterial compound | TLR1, MPO, O60361 | LMNA 4477/4885BLM 2245/4885PTPN1 1557/4885 |
| US-20120014901-A1 | Rinse-Off Conditioning Composition Comprising a Near-Terminal Branched Alcohol | ITGB7, ARG1, ITGB1 | LMNA 296/4885BLM 805/4885PTPN1 3503/4885 |
| US-20020161221-A1 | Ether type lipid a 1-carboxylic acid analogs | MSR1, ELOVL1, FFAR1 | LMNA 2438/4885BLM 4556/4885PTPN1 1322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.